Alchemab Therapeutics
Harry D. is an experienced software engineering professional with a strong background in software development and team leadership. Currently serving as a Senior Software Engineer and LIMS Developer at Alchemab Therapeutics Ltd since February 2022, Harry D. has previously held positions including Software Engineer at Tailor Bio and Software Engineer Team Lead at Cambridge Cancer Genomics. With early career roles as a Junior Software Engineer at SimOmics Ltd. and Junior Software Developer at SmartTHING Limited, Harry D. has progressively developed expertise in the field. Additionally, experience as a 3D Spatial Modelling Analyst at NM Group and a Software Project Assistant at The University of York Students' Union demonstrates versatility. Harry D. holds a Bachelor of Engineering (BEng) in Electronics and Computer Engineering from the University of York and has participated in relevant coursework through Coursera.
This person is not in any offices
Alchemab Therapeutics
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development.